Shares of ALT5 Sigma Corporation (NASDAQ:ALTS - Get Free Report) shot up 6.5% on Wednesday . The stock traded as high as $7.68 and last traded at $7.66. 210,758 shares changed hands during trading, a decline of 10% from the average session volume of 234,322 shares. The stock had previously closed at $7.19.
ALT5 Sigma Price Performance
The firm's 50-day moving average price is $8.13 and its 200 day moving average price is $6.27. The company has a current ratio of 0.83, a quick ratio of 0.83 and a debt-to-equity ratio of 1.26.
ALT5 Sigma Company Profile
(
Get Free Report)
ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments.
Recommended Stories
Before you consider ALT5 Sigma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ALT5 Sigma wasn't on the list.
While ALT5 Sigma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
